By Sarah Jane Tribble   Kip Burgess was relieved last year when pharmaceutical giant Amgen overnighted him a $2,976 check to help pay for his go-to arthritis drug, Enbrel. The 36-year-old psychologist had run into an increasingly common problem: The copay coupon sent by Thousand Oaks, Calif.-based Amgen

By Vanessa Salvia In the elegant Presidential Ballroom of the Gaylord Opryland Resort in Nashville, Martin “Marty” Makary, MD, addressed American College of Phlebology’s 32nd Annual Congress attendees eager to hear his message about how the program Improving Wisely is helping to reduce waste in healthcare. More than 1,200 registrants,

Now that everyone has said yes, Boston Scientific has gone to the banks to sign a number of new lending agreements, including a large credit facility it could use to finance its $4.2 billion acquisition offer for British medical device maker BTG plc. The information, which came from recently posted

Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders of BTG’s

New patient relationship categories and codes are one of the most important provisions of the Medicare Access and CHIP Reauthorization Act (MACRA), according to a piece in the New England Journal of Medicine. In January 2018, the billing-code modifiers, which allow clinicians to report their relationship to a patient at a

    “My veins are covered by insurance, right? But, the XYZ Insurance Co. representative said my varicose veins are a covered benefit on my insurance plan.”    By James White, MD How many times have these words been uttered by potential patients upon arrival to our vein clinics? Yet,

    The CEO of Vein911 Vein Treatment Centers, 21-year cancer survivor and healthcare industry veteran Chris Pittman, MD, has launched Health Performance Specialists (HPS), a national Management Services Organization for independent physicians. HPS helps independent physicians compete, succeed and thrive in today’s medical practice environment. The organization is designed to disrupt current healthcare

    Boston Scientific has reached an agreement on the terms of a recommended offer to acquire BTG plc., a United Kingdom-based company that develops and commercializes products used in minimally-invasive procedures, targeting vascular diseases and cancer, as well as acute care pharmaceuticals. Under the terms of the transaction, holders

  BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the

The Centers for Medicare & Medicaid Services (CMS) released the final 2019 Physician Fee Schedule (PFS) and the Quality Payment Program (QPP) rule Nov. 1. According to CMS officials, the final rule modernizes Medicare payment policies to promote access to virtual care, saving Medicare beneficiaries time and money while improving